-
As BA.2 Continues Rapid Northeast Rise, Here Are COVID Symptoms to Watch For
With the BA.2 omicron subvariant continuing to spread across Massachusetts, Boston and the U.S., what symptoms should you be watching for? The “stealth omicron” subvariant has only been the dominant strain of COVID in the United States for less than a month, but the Centers for Disease Control and Prevention now believes that it is responsible for more than 80%...
-
What is Omicron BA.2?
Omicron BA.2, also known as “stealth omicron,” has been the dominant strain of COVID-19 in the U.S. since March 2022.
-
BA.2 Now Responsible for 84% of New England's COVID Infections
The so-called “stealth” omicron variant BA.2, which is fueling a fresh COVID case uptick locally, nationally and abroad, now accounts for 84% of virus circulating in New England, a significantly higher prevalence than its national share and a marked increase in the last week, according to new CDC data released Tuesday. For the New England area, which includes Connecticut, Maine,…
-
BA.2 Variant Now Accounts for 73% of COVID Cases in New England, CDC Says
Rising infections associated with the so-called “stealth” omicron variant BA.2 are fueling concerns that the U.S. could soon experience another COVID-19 wave. According to the CDC, that variant accounts for 72.6% of COVID circulating in New England. By comparison, it is responsible for 54.9% of new infections nationally. BA.2, also known as “stealth omicron,” is considered a subvariant of omicron….
-
Symptoms, Transmissibility, and More: What We Know About the BA.2 Subvariant
What is the BA.2 omicron subvariant and will it lead to another surge in the U.S.? Experts say what happens in the next few weeks in the U.S. could be critical to whether or not the U.S. will follow in Europe’s footsteps. As most COVID-19 restrictions are relaxed across Europe, including Austria, Britain, Denmark, Germany and France, the numbers...
-
‘Stealth' COVID Variant Accounts for Over 50% of COVID Cases in New England
Rising COVID infections associated with the so-called “stealth” omicron variant BA.2 are fueling fresh leeriness about the state of the pandemic in Massachusetts and across the country, just as life as we now know it is beginning to return to normal. According to the CDC, that variant accounts for 55.4% of COVID circulating in New England. By comparison, it’s responsible…
-
Should You Be Concerned About New COVID Variant BA.2?
It’s been called “stealth omicron” or “deltacron.” A new subvariant of the COVID-19 virus is making headlines, so we talked to NBC News medical correspondent Dr. John Torres to learn more. He explained how the variant “plagiarizes” from the Omicron and Delta variants that previously caused surges, and why this may not cause a new surge here in the...
-
Mass. Health Officials Keeping a Careful Eye on COVID-19 Cases Abroad
Local doctors are keeping a close eye on the surging COVID-19 cases in Europe, saying we need to prepare for the next wave in the United States. A new subvariant of omicron, called BA.2, is fueling an outbreak overseas, and people back here at home are frustrated. “I wouldn’t say I’m numb to it, but I’m definitely exhausted,” said...
-
Keeping an Eye on Rising COVID-19 Cases Overseas
A new subvariant of omicron, BA.2 is fueling a COVID-19 outbreak overseas, but it’s too soon to know exactly how it will play out in the U.S.
-
How Worried Should You Be About ‘Stealth Omicron'? Here's What Boston Experts Say
With COVID outbreaks being reported in a number of countries around the world and upticks being seen across Europe, many coinciding with a rise in BA.2 or “stealth omicron” cases, how worried should you be? Three top Boston doctors said this week it remains unclear what effect the BA.2 subvariant will have on the city’s fight against COVID, though...
-
COVID Q&A: Top Boston Doctors Talk Deltacron, 4th Vaccine Dose
Top Boston doctors talked about a new “Deltacron” variant, rising cases in Europe and Asia and whether a fourth vaccine dose is really necessary on NBC10 Boston’s weekly “COVID Q&A” series.